David Sidransky

David Sidransky

Founder presso CHAMPIONS ONCOLOGY, INC.

Patrimonio netto: 4 M $ in data 29/02/2024

64 anni
Health Technology
Consumer Services
Health Services

Profilo

David Sidransky is a businessperson who founded Champions Oncology, Inc. and Israel Biotech Fund and who has been at the helm of 7 different companies.
Dr. Sidransky occupies the position of Chairman at Biosight Therapeutics, Inc., Chairman at Ayala Pharmaceuticals, Inc., Chairman at Old Ayala, Inc. (a subsidiary of Ayala Pharmaceuticals, Inc.) and General partner at Israel Biotech Fund.
David Sidransky is also Professor at The Johns Hopkins University, Member of American Society of Clinical Oncology, Inc., Executive Officer for Biomerk, Inc., Director-Head & Neck Cancer Research Division at The Sidney Kimmel Comprehensive Cancer Center, Professor at The Johns Hopkins University School of Medicine and Member of The American Association of Cancer Research and on the board of 9 other companies.
He previously was Chairman for Tamir Biotechnology, Inc., Chairman of Advaxis, Inc., Chairman of Old Ayala, Inc. and Senior Editor at Clinical Cancer Research.
He received an undergraduate degree from Brandeis University and a doctorate from Baylor College of Medicine.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
03/11/2023 767 043 ( 5.64% ) 4 M $ 29/02/2024
15/03/2023 500 ( 0.01% ) 198 $ 29/02/2024
12/12/2022 93 ( 0.00% ) 80 $ 29/02/2024
20/12/2023 0 ( -.--% ) - $ 29/02/2024

Posizioni attive di David Sidransky

SocietàPosizioneInizio
IMMUNE PHARMACEUTICALS, INC. Director/Board Member 26/08/2013
ORGENESIS INC. Director/Board Member 18/07/2013
CHAMPIONS ONCOLOGY, INC. Founder 01/01/2008
ROSETTA GENOMICS LTD. Director/Board Member 22/12/2009
GALMED PHARMACEUTICALS LTD. Director/Board Member 01/06/2014
ADVAXIS, INC. Chairman 01/05/2019
CACTUS ACQUISITION CORP. 1 LIMITED Director/Board Member -
ASCENTAGE PHARMA GROUP INTERNATIONAL Director/Board Member 31/03/2021
AYALA PHARMACEUTICALS, INC. Chairman 01/11/2017
░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Tutte le posizioni attive di David Sidransky

Precedenti posizioni note di David Sidransky

SocietàPosizioneFine
░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di David Sidransky

Formazione di David Sidransky

Brandeis University Undergraduate Degree
Baylor College of Medicine Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di David Sidransky

Relazioni

99

Relazioni di 1° grado

32

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa8
ROSETTA GENOMICS LTD.

Health Technology

ORGENESIS INC.

Health Technology

CARDIFF ONCOLOGY, INC.

Health Technology

GALMED PHARMACEUTICALS LTD.

Health Technology

ASCENTAGE PHARMA GROUP INTERNATIONAL

Health Technology

AKARI THERAPEUTICS, PLC

Health Technology

CACTUS ACQUISITION CORP. 1 LIMITED

Finance

AYALA PHARMACEUTICALS, INC.

Commercial Services

Aziende private20

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Champions Oncology, Inc.

Clinical Cancer Research

Commercial Services

Health Services

Health Services

National Institute of Dental & Craniofacial Research

Government

Health Technology

Health Technology

Finance

Health Technology

Health Technology

The American Association of Cancer Research

Health Services

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. David Sidransky